Article info
PDFClinical trial
A phase III randomized clinical trial comparing sentinel node biopsy with no retroperitoneal node dissection in apparent early-stage endometrial cancer – ENDO-3: ANZGOG trial 1911/2020
- Correspondence to Professor Andreas Obermair, Queensland Centre for Gynaecological Cancer Research, The University of Queensland, Brisbane, Queensland, Australia; a.obermair{at}uq.edu.au
Citation
A phase III randomized clinical trial comparing sentinel node biopsy with no retroperitoneal node dissection in apparent early-stage endometrial cancer – ENDO-3: ANZGOG trial 1911/2020
Publication history
- Accepted October 13, 2021
- First published November 2, 2021.
Article Versions
- You are currently viewing a Previous version of this article (10 January 2022).
- View the most recent version of this article
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© IGCS and ESGO 2021. No commercial re-use. See rights and permissions. Published by BMJ.